Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
about
The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial FibrillationEHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis.Atrial fibrillation and the risk of myocardial infarction.Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillationAtrial fibrillation and stroke: what we know, what's new, and what we should do now.Platelet dysfunction in thrombosis patients treated with vitamin K antagonists and recurrent bleeding.Diagnostic value of D-dimer and antithrombin-III levels in predicting prosthetic heart valve thrombosis.The effects of magnesium on the course of atrial fibrillation and coagulation in patients with atrial fibrillation undergoing mitral valve annuloplastyFibrinogen: biochemistry, epidemiology and determinants.Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillationAssociation of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.Prevention of venous thromboembolism after stroke.Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) StudyEffects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillationP-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.Embolic Stroke Diagnosed by Elevated D-Dimer in a Patient With Negative TEE for Cardioembolic SourceEffect of heart rate control on coagulation status in patients of rheumatic mitral stenosis with atrial fibrillation--A pilot studyvon Willebrand factor and its relevance to cardiovascular disordersHaemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation.Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxabanMechanisms And Management Of Thrombo-Embolism In Atrial FibrillationCardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.Effect of Oral Anticoagulant Therapy on Coagulation Activity and Inflammatory Markers in Patients with Atrial Fibrillation Undergoing Ablation: A Randomized Comparison between Dabigatran and Warfarin.Assessment of endothelial (dys)function in atrial fibrillation.Fluctuations in coagulation activity among patients with atrial fibrillation who are stably anticoagulated.Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation.Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk.Clopidogrel hydrogen sulphate for atrial fibrillation.Biomarkers in atrial fibrillation: a clinical review.Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence.Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapyPlatelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review.Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review.Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.Hypercoagulability and haemodynamic abnormalities in atrial fibrillation.Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?Albumin level and stroke. Potential association between lower albumin level and cardioembolic aetiology.
P2860
Q26747263-3C4C1D49-BAD5-4B18-B288-66A346C89314Q30375302-2CFCCBE7-2A9F-44F1-9F84-5C2EF51EF249Q33712583-A86326C2-6A09-4D19-9D47-3651C55B4285Q33970602-E07F78EF-4BE4-46E8-B964-491AB50C29A0Q34025555-AB1025CE-0FC6-4CE8-8141-C2E80F87B1F7Q34025564-F22C646E-91F6-4680-9ACA-6FC441007A23Q34749456-101D80A8-E949-42E1-A87E-40C348B49F3AQ34796486-DFD31F46-1BA9-41ED-9033-8BB1151EAF7BQ35406672-4B46F408-E66D-4F54-9F97-F7CAB500C7CDQ35538771-D63821BB-6E9E-42D0-88D7-2B7916502FBBQ35582996-9956AE01-1F1F-4E0B-964A-90AFD9280C70Q35605552-F34ABBCE-6A7F-48D2-908B-701614FD4955Q35610118-8CB421A4-C096-4474-99B1-EC12075B1D65Q35661109-D5D9FBD2-0884-4CC5-9A41-EC04DFE22D01Q35773343-4887D388-9BD2-4C71-9193-CEE1CAECFE29Q35811705-3B4A3B7D-8389-4BC6-BE28-B76E93F0334FQ35927655-B38F89DB-A1B1-4D94-B79C-B575F7117604Q36396662-7C0B9BF2-A426-40DE-8381-F66A7DFC7DDAQ36825948-79F5142F-FC00-4CD3-9717-36ED37A1A304Q36843189-183677D5-4A03-4D97-A55B-B2F40BCAB201Q37085638-17B17D96-8BC8-496E-AC69-BEE1748203D8Q37115524-E22F821C-73B7-4D25-AA34-4A3078E997CEQ37464600-B2DFC425-2C3D-4412-8019-702EA5F91816Q37468947-BB69EA1E-AED0-4D87-901C-AD99B22FFE95Q37495877-272A5960-8040-46E7-8234-81910FCD9F9AQ37576987-AD779DA1-2967-40DC-98EA-FD338CF1F19FQ37587835-F509EBC5-D3A6-44A5-A6DF-384BE85F9E6AQ37608475-F6F6800F-10EC-478C-B49D-91778430F8E0Q37629177-FC23C524-D593-4E6F-933B-82CD66353011Q37777419-31575813-0037-48DD-B0A1-421BF6BD7733Q37887815-5AC33746-E20F-44AF-BF4B-AC0EBD0210E2Q38079565-87D98C70-C5B7-474A-BDF7-ED8FBE4C7169Q38215163-24C1A168-3703-47E4-9116-7C4A667BDBCDQ38646824-EEB4E89F-907C-4B06-9F76-9DFDA77E4805Q39182923-C10F0F15-96E5-4F71-B475-E1EEB1527E87Q39209674-E32D634C-A7F1-418A-84DC-0B8287752237Q39364345-E1D120DD-C471-4C6F-994E-D80BE6E1842AQ41343151-CC174293-C530-4D88-A6A3-7631FB0C8971Q41857087-3D47EE3D-9123-438C-A0B3-E1B67212C324Q44749615-086951B7-4871-4A03-8EFE-3BC155363B06
P2860
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Increased markers of thromboge ...... effects of warfarin treatment.
@en
type
label
Increased markers of thromboge ...... effects of warfarin treatment.
@en
prefLabel
Increased markers of thromboge ...... effects of warfarin treatment.
@en
P2093
P2860
P356
P1476
Increased markers of thromboge ...... effects of warfarin treatment.
@en
P2093
P2860
P304
P356
10.1136/HRT.73.6.527
P577
1995-06-01T00:00:00Z